RHHBY Roche Holding AG
Stock Price & Overview

$40.910.93 (+2.33%)1:17 PM 06/04/25
OTCQX | $USD | Delayed

RHHBY Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

Ratings Summary

People Also Follow

Similar to RHHBY

ETFs Holding RHHBY

RHHBY Company Profile

Roche Holding AG logo
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Employees
103,249
Founded
1896
Address
  • Grenzacherstrasse 124
  • Basel, 4070
  • Switzerland
Phone Number
41 61 688 88 80

RHHBY Revenue

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

RHHBY Dividend Growth History

RHHBY Ownership

RHHBY Peers

Risk

Technicals

RHHBY Transcripts

Investor Presentations

RHHBY SEC Filings

RHHBY Income Statement

RHHBY Balance Sheet

RHHBY Cash Flow Statement

RHHBY Long Term Solvency

Roche Holding AG (RHHBY) Frequently Asked Questions